Clinical Trial Update: A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial of SK-PC-B70M for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• SK-PC-B70M

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED